Wusson Accelerator AB

Multiplex immunofluorescence chemistries with ZEISS tissue multiplexing workflow

Bringing leading multiplex immunofluorescence chemistries together in one automated 8-channel imaging platform.

ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment

Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care.

Genmab to Acquire Dutch biotech for USD 8 Billion

Danish pharmaceutical company Genmab has agreed to acquire Dutch firm Merus, a developer of cancer therapies, for USD 8 billion, equivalent to nearly SEK 75 billion.

ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.

Novo Nordisk tells staff to return to office

At the turn of the year, Novo Nordisk employees will no longer be able to work remotely. According to the company’s new CEO, the move is intended to accelerate ...

Roche joins Medicon Village

Roche and Medicon Village Innovation have signed an agreement for deeper collaboration. “The fact that Roche is now becoming part of this environment further st...

New ATMP center inaugurated: “In the future, we will see cell and gene therapies in all clinics”

Karolinska Institutet and Karolinska University Hospital’s new ATMP center was inaugurated in Flemingsberg, south of Stockholm. “The ATMP Center is not just a p...

Will the FDA’s new transparency policy extend to medical devices? (Part 1)

In a significant policy shift, the FDA has begun publishing Complete Response Letters (CRLs) for drug and biologic applications that were initially rejected but...

Orbán's extended arm becomes health commissioner in the EU

Hungarian Olivér Várhelyi may soon become the most influential official for the healthcare and pharmaceutical industry in the EU. Várhelyi, who is close to Hung...

Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

A cluster contribution to European life science innovation and competitiveness?

Elypta ska växa med hjälp av europeisk accelerator

Det svenska diagnostikbolaget Elypta, som utvecklar metoder för tidig upptäckt av cancer, har antagits som medlem i det europeiska acceleratorprogrammet EIC Scaling Club.

ZEISS unveils AI-powered Research Data Platform

Collaboration with Boehringer Ingelheim champions the future of personalized eye care.

ZEISS introduces the new Smartzoom 100

The future of digital microscopy for efficient optical inspections.

Utveckling av svensk KOL-behandling får stöd av amerikansk accelerator

Nystartade Mucolife Therapeutics, som utvecklar ett läkemedel mot lungsjukdomen KOL, har ingått partnerskap med ett amerikanskt acceleratorprogram.

Alzecure får EU-miljoner till alzheimerstudie

Alzecure Pharma beviljas 2,5 miljoner euro, motsvarande 28 miljoner kronor, i EU-anslag för sitt projekt inom Alzheimers sjukdom.

FDA plans to replace animal testing with AI – “Paradigm shift”

The requirement for animal testing in drug development will be phased out and replaced by AI, according to an announcement by the FDA. The decision has been met...

Sahlgrenska Science Park

Kompauto Nordic AB

Metabolon

ProPharma

Clinigen Clinical Supplies Management GmbH

LINK Medical Research